What is the most recent earnings date for PHXM stock?
PHAXIAM Therapeutics SA (PHXM) last reported earnings on 11/14/2023.
NASDAQ:PHXM • US29604W2070
Past quarterly earnings results for PHAXIAM Therapeutics SA (PHXM), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in EUR): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2023 | -0.12 | - | 93.89% | 197K | - | -58.00% | ||
| Q2 2023 | -0.12 | - | 80.53% | 278K | - | -70.86% | ||
| Q1 2023 | -1.10 | - | 57.45% | 299.88K | - | -88.24% | ||
| Q4 2022 | -0.99 | - | 62.50% | 5.694M | 714K | 697.48% | 272.16% | |
| Q3 2022 | -1.99 | - | 38.98% | 469K | - | -69.35% | ||
| Q2 2022 | -0.59 | -3.09 | 80.74% | 81.72% | 954K | 2.55M | -62.59% | - |
| Q1 2022 | -2.59 | - | - | 2.55M | - | - | ||
| Q4 2021 | -2.65 | - | - | 1.53M | - | - | ||
| Q3 2021 | -3.25 | - | - | 1.53M | - | - | ||
| Q2 2021 | -3.25 | - | - | - | - |
Notes
PHAXIAM Therapeutics SA (PHXM) last reported earnings on 11/14/2023.
PHAXIAM Therapeutics SA (PHXM) missed EPS estimates and missed revenue estimates in the most recent quarter.